SPT3162 ( DrugBank: - )
1 disease
| 告示番号 | 疾患名(ページ内リンク) | 臨床試験数 | 
|---|---|---|
| 145 | ウエスト症候群 | 2 | 
145. ウエスト症候群
臨床試験数 : 43 / 薬物数 : 54 - (DrugBank : 15) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 24
| No. | TrialID | Date_ enrollment  | Date_ registration  | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor  | Secondary_ sponsor  | Recruitment_ Status  | Inclusion_ agemin  | Inclusion_ agemax  | Inclusion_ gender  | Target_ size  | Phase | Countries | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2006-004286-33-CZ (EUCTR)  | 11/05/2007 | 30/03/2007 | An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spasms. | An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spasms. | Infantile spasms  MedDRA version: 9.1;Level: LLT;Classification code 10021750;Term: Infantile spasms  | Product Name: Ganaxolone Product Code: SPT3162 Other descriptive name: Ganaxolone  | Marinus Pharmceuticals, Inc. | NULL | Not Recruiting | Female: yes Male: yes  | 54 | Czech Republic | |||
| 2 | EUCTR2006-004286-33-PL (EUCTR)  | 04/06/2007 | An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spansms. | An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spansms. | Infantile spasms  MedDRA version: 9.1;Level: LLT;Classification code 10021750;Term: Infantile spasms  | Product Name: Ganaxolone Product Code: SPT3162  | Marinus Pharmceuticals, Inc. | NULL | NA | Female: yes Male: yes  | 54 | Phase 2 | Czech Republic;Poland |